NL-OMON37855
Completed
Not Applicable
Validation of dried blood spot sampling in therapeutic drug monitoring of nilotinib - Dried Blood Spot Nilotinib
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Chronic Myelogenous Leukemia
- Sponsor
- Vrije Universiteit Medisch Centrum
- Enrollment
- 40
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with CML who are treated with nilotinib.
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Validation of dried blood spot sampling in therapeutic drug monitoring of cyclosporiTransplantation of hematopoetic stem cells or kidney10003816NL-OMON34000Vrije Universiteit Medisch Centrum40
Completed
Not Applicable
Clinical validation of the dried blood spot analysis for antituberculosis drugsBlood concentration of anti TB drugs10028440NL-OMON34891niversitair Medisch Centrum Groningen33
Completed
Not Applicable
Clinical validation of a dried blood spot (DBS) method for the analysis of immunosuppressive and antifungal drugs in pediatric patients (part of the PROTECT study).immuunsuppressie na niertransplantatieanalysis of drug used in renal transplantation / analysis of drug used in invasive fungal infections10017528NL-OMON44369Afdeling Apotheek89
Withdrawn
Not Applicable
Clinical validation of a dried blood spot (DBS) method for the analysis of rifampicin (RIBOD study).analysis of drugs used for tuberculosis10004018NL-OMON42070niversitair Medisch Centrum Sint Radboud10
Not yet recruiting
Not Applicable
Validation of a finger prick capillary blood sampling test for home monitoring of C-reactive protein and therapeutic drug monitoring of biological therapy in patients with inflammatory bowel diseaseNL-OMON51794niversitair Medisch Centrum Groningen64